Talk:Endocannabinoid system in appetite regulation: Difference between revisions
Jump to navigation
Jump to search
imported>Gareth Leng No edit summary |
imported>Anthony.Sebastian (→Re effects of rimonabant: new section) |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{subpages}} | |||
This article, now donated to Citizendium, is modified from one I placed on the Diabesity website [http://www.eurodiabesity.org/adipocyte.htm]. I am a member of the Diabesity consortium and the article was originally written by a student, under my supervision, with the intent that it should be freely available to the public.[[User:Gareth Leng|Gareth Leng]] 09:24, 1 August 2007 (CDT) | This article, now donated to Citizendium, is modified from one I placed on the Diabesity website [http://www.eurodiabesity.org/adipocyte.htm]. I am a member of the Diabesity consortium and the article was originally written by a student, under my supervision, with the intent that it should be freely available to the public.[[User:Gareth Leng|Gareth Leng]] 09:24, 1 August 2007 (CDT) | ||
== Re effects of rimonabant == | |||
Gareth, should the article mention the increased risk of adverse psychiatric effects of rimonabant? http://dx.doi.org/10.1016/S0140-6736(07)61721-8 [[User:Anthony.Sebastian|Anthony.Sebastian]] 00:38, 21 May 2009 (UTC) |
Latest revision as of 19:38, 20 May 2009
This article, now donated to Citizendium, is modified from one I placed on the Diabesity website [1]. I am a member of the Diabesity consortium and the article was originally written by a student, under my supervision, with the intent that it should be freely available to the public.Gareth Leng 09:24, 1 August 2007 (CDT)
Re effects of rimonabant
Gareth, should the article mention the increased risk of adverse psychiatric effects of rimonabant? http://dx.doi.org/10.1016/S0140-6736(07)61721-8 Anthony.Sebastian 00:38, 21 May 2009 (UTC)